SS
MRNA icon

Steve Schonfeld’s Moderna MRNA Stock Holding History

Steve Schonfeld’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,700
Closed -$577K – 2862
2022
Q3 		$577K Hold
13,700
– – ﹤0.01% 1653
2022
Q2 		$1.96M Buy
+13,700
New +$1.96M 0.02% 751
2021
Q4 		– Sell
-100,000
Closed -$38.5M – 2395
2021
Q3 		$38.5M Buy
+100,000
New +$36.9M 0.4% 44

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Steve Schonfeld's MRNA Position: Q2 2026 in Review

Steve Schonfeld sold out of Moderna (MRNA) in Q2 2026, closing a stake of 15,691 shares — an estimated $797K sold.

Steve Schonfeld first reported a position in MRNA in Q1 2020 and held it in 19 quarters. The position peaked at $16.5M in Q2 2024. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Steve Schonfeld reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 15,691 Moderna shares in Q2 2026, an estimated $797K.
  • Steve Schonfeld first reported a position in Moderna in Q1 2020 and held it in 19 quarters.
  • Steve Schonfeld's Moderna position peaked at $16.5M in Q2 2024.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.